Adel 17 (Glautaract)

INDICATIONS: Supportive treatment for early stage of loss of sight due to cataract, glaucoma and conjunctivitis as part of a complex treatment.

Degenerative processes often contribute to reduction in visual power. Beginning with a blockage of the flow of the aqueous humor, this degeneration can lead to glaucoma and cataracts, where the lens becomes clouded. Reversing this degeneration in its different stages requires a the comprehensive treatment of the metabolism. When used as a long-term therapy, ADEL 17 (GLAUTARACT) drops helps effectively treat glaucoma, disturbed circulation to the eye, inflammation of the iris and cornea, sclerotic vessels and weak vision.

RECOMMENDED DOSAGE: (Unless otherwise prescribed)
Adults 20 drops, 3 times a day in some liquid before meals.